Patents by Inventor Matthew Lucas

Matthew Lucas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and uses thereof
    Patent number: 12268687
    Abstract: The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: April 8, 2025
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Iwona Wrona, Kerem Ozboya, Matthew Lucas, Bhaumik Pandya, Bertrand Le Bourdonnec
  • Articulated arm coordinate measuring machine
    Patent number: 12246442
    Abstract: An articulated arm coordinate measuring machine includes an arm having multiple segments and an end assembly. The end assembly has multiple accessory interfaces that allow multiple accessories to be coupled to the end assembly. The accessory interfaces are configured to allow the accessories to be repeatably interchanged between the accessory interfaces.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: March 11, 2025
    Assignee: FARO Technologies, Inc.
    Inventors: John Lucas Creachbaum, Brent Bailey, William E. Schoenfeldt, Fabiano Kovalski, Eduardo Laranjeira, Chad Crisostomo, Michael Bartel, Kishore Lankalapalli, Christopher M. Riehl, Matthew Mogensen
  • ADAPTIVE STREAMING OF MULTIMEDIA CONTENT
    Publication number: 20250071164
    Abstract: The present disclosure describes a method and system for adaptively streaming multimedia content. Data relating to the multimedia content is separated into a plurality of components, each of the components corresponding to one or more features of the multimedia content. The plurality of components are prepared for transmission to a client device, wherein a different preparation is applied to each component depending on the one or more features of a respective component. The prepared components are transmitted from the server to the client device.
    Type: Application
    Filed: August 20, 2024
    Publication date: February 27, 2025
    Applicant: Sony Interactive Entertainment Europe Limited
    Inventors: Maurizio CERRATO, Rajeev GUPTA, Christopher William HENDERSON, Marina VILLANUEVA-BARREIRO, Jesus Lucas BARCIAS, Marcos CONDE, Matthew William SANDERS, Rosario LEONARDI
  • COMPOUNDS AND USES THEREOF
    Publication number: 20250034124
    Abstract: The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.
    Type: Application
    Filed: September 20, 2024
    Publication date: January 30, 2025
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Iwona WRONA, Kerem OZBOYA, Matthew LUCAS, Bhaumik PANDYA, Bertrand LE BOURDONNEC
  • ELECTRONIC THREAT ASSESSMENT SYSTEM
    Publication number: 20250036606
    Abstract: A system for assessing threats includes a method of detecting a physical location of the system, establish a connection to at least one database, scanning a proximate area, prioritizing a plurality of identified objects, comparing data for at least one of the identified object to data from the at least one database, and outputting at least one notification.
    Type: Application
    Filed: October 8, 2024
    Publication date: January 30, 2025
    Inventors: James Matthew Underwood, Larry Cullen Underwood, Davidson Glenn Lucas
  • COMPOUNDS AND USES THEREOF
    Publication number: 20250034125
    Abstract: The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.
    Type: Application
    Filed: September 20, 2024
    Publication date: January 30, 2025
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Iwona WRONA, Kerem OZBOYA, Matthew LUCAS, Bhaumik PANDYA, Bertrand LE BOURDONNEC
  • Compounds and uses thereof
    Patent number: 12180221
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: December 31, 2024
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Bertrand Le Bourdonnec, Matthew Lucas, Kerem Ozboya, Bhaumik Pandya, Parcharee Tivitmahaisoon, Iwona Wrona
  • CONDITIONALLY ACTIVE PROTEINS FOR NEURODEGENERATIVE DISEASES
    Publication number: 20240400659
    Abstract: A polypeptide or conditionally active protein suitable for prevention or treatment of a neurodegenerative disease that binds to ApoE. The conditionally active protein binds to ApoE with an increased binding activity at an aberrant condition such as an acidic pH in a dementia brain in comparison with the binding activity to ApoE at a normal physiological condition such as the pH of blood. A method for generating the conditionally active protein is also provided.
    Type: Application
    Filed: October 17, 2022
    Publication date: December 5, 2024
    Applicant: BioAtla, Inc.
    Inventors: Jay M. Short, Christina Wheeler, Jing Wang, Matthew Lucas, Haizhen Liu, Hwai Wen Chang, Gerhard Frey
  • COMPOUNDS AND USES THEREOF
    Publication number: 20240400546
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: April 29, 2024
    Publication date: December 5, 2024
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Bertrand LE BOURDONNEC, Matthew LUCAS, Kerem OZBOYA, Bhaumik PANDYA, Parcharee TIVITMAHAISOON, Iwona WRONA
  • GUIDEWIRE INSERTION AIDES FOR PERCUTANEOUS CIRCULATORY SUPPORT DEVICES
    Publication number: 20240325725
    Abstract: A percutaneous circulatory support system includes a percutaneous circulatory support device having an impeller and a distal portion. A guidewire insertion aide is removably carried in the distal portion of the percutaneous circulatory support device. The guidewire insertion aide includes a tapered distal end portion initially in contact with the distal portion of the percutaneous circulatory support device. The guidewire insertion aide is configured to couple to a guidewire.
    Type: Application
    Filed: March 26, 2024
    Publication date: October 3, 2024
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Brice Lee Shireman, Jeffrey Matthew Lucas, Brian R. Reynolds, Qian Liu
  • Compounds and uses thereof
    Patent number: 12098146
    Abstract: The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: September 24, 2024
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Iwona Wrona, Kerem Ozboya, Matthew Lucas, Bhaumik Pandya, Bertrand Le Bourdonnec
  • COMPOUNDS AND USES THEREOF
    Publication number: 20240300938
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: April 29, 2024
    Publication date: September 12, 2024
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Bertrand LE BOURDONNEC, Matthew LUCAS, Kerem OZBOYA, Bhaumik PANDYA, Parcharee TIVITMAHAISOON, Iwona WRONA
  • PYRIDOPYRIMIDINES AND METHODS OF THEIR USE
    Publication number: 20240208964
    Abstract: Disclosed are compounds useful in the treatment of neurological disorders. The compounds described herein, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological diseases.
    Type: Application
    Filed: June 3, 2021
    Publication date: June 27, 2024
    Inventors: Kerem OZBOYA, Iwona WRONA, Bertrand LE BOURDONNEC, Matthew LUCAS, Vanessa KURIA, Madeline MACDONNELL, Byron DELABARRE
  • PURINES AND METHODS OF THEIR USE
    Publication number: 20240150358
    Abstract: Disclosed are compounds useful in the treatment of neurological disorders. The compounds described herein, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological diseases.
    Type: Application
    Filed: June 3, 2021
    Publication date: May 9, 2024
    Inventors: Kerem OZBOYA, Iwona WRONA, Bertrand LE BOURDONNEC, Matthew LUCAS, Vanessa KURIA, Madeline MACDONNELL, Byron DELABARRE
  • Compounds and uses thereof
    Patent number: 11970486
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: April 30, 2024
    Assignee: Janssen Pharmaceutica NV
    Inventors: Bertrand Le Bourdonnec, Matthew Lucas, Kerem Ozboya, Bhaumik Pandya, Parcharee Tivitmahaisoon, Iwona Wrona
  • COMPOUNDS AND USES THEREOF
    Publication number: 20240124435
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 18, 2024
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Matthew Lucas, Bertrand Le Bourdonnec, Iwona Wrona, Bhaumik Pandya, Parcharee Tivitmahaisoon, Kerem Ozboya, Benjamin Vincent, Daniel Tardiff, Jeff Piotrowski, Eric Solis, Robert Scannevin, Chee-Yeun Chung, Rebecca Aron, Kenneth Rhodes
  • METHODS OF STRATIFYING PATIENTS FOR TREATMENT WITH RETINOIC ACID RECEPTOR-ALPHA AGONISTS
    Publication number: 20240102106
    Abstract: Described herein are methods that define cellular populations that are sensitive to RARA agonists and identify patient populations that will benefit from treatment with RARA agonists. The methods may comprise administering RARA agonists to patient populations.
    Type: Application
    Filed: June 16, 2023
    Publication date: March 28, 2024
    Inventors: Michael Robert McKeown, Christopher M. Fiore, Matthew Lucas Eaton, Emily Payton Lee, Christian Fritz
  • METHOD OF TREATING CANCERS WITH ALKYNE SUBSTITUTED QUINAZOLINE DERIVATIVES
    Publication number: 20240075042
    Abstract: The present disclosure relates to methods of treating or preventing cancer (e.g., advanced solid cancer) using Compound No. 1 or Compound No. 2: or a pharmaceutically acceptable salt thereof. The present disclosure also relates to pharmaceutical compositions and pharmaceutical kits suitable for the treatment or prevention.
    Type: Application
    Filed: November 2, 2021
    Publication date: March 7, 2024
    Inventors: Elizabeth BUCK, Matthew O'CONNOR, Darlene ROMASHKO, Tai-An LIN, Alexander FLOHR, Luca ARISTA, Iwona WRONA, Matthew LUCAS, Chris ROBERTS, Giorgio OTTAVIANI, Sherri SMITH, Nigel WATERS
  • Compounds and uses thereof
    Patent number: 11873298
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: January 16, 2024
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Matthew Lucas, Bertrand Le Bourdonnec, Iwona Wrona, Bhaumik Pandya, Parcharee Tivitmahaisoon, Kerem Ozboya, Benjamin Vincent, Daniel Tardiff, Jeff Piotrowski, Eric Solis, Robert Scannevin, Chee-Yeun Chung, Rebecca Aron, Kenneth Rhodes
  • AMINO ALCOHOL COMPOUNDS AND USES THEREOF
    Publication number: 20230339890
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: June 3, 2021
    Publication date: October 26, 2023
    Inventors: Iwona WRONA, Kerem OZBOYA, Bertrand LE BOURDONNEC, Vanessa KURIA, Madeline MACDONNELL, Matthew LUCAS, Byron DELABARRE